Pictet North America Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.83M | Sell |
|
|||||
|
2025
Q1 | $7.2M | Buy |
|
|||||
|
2024
Q4 | $6.26M | Buy |
|
|||||
|
2024
Q3 | $2.37M | Hold |
|
|||||
|
2024
Q2 | $2.37M | Sell |
|
|||||
|
2024
Q1 | $4.25M | Sell |
|
|||||
|
2023
Q4 | $4.89M | Sell |
|
|||||
|
2023
Q3 | $5.37M | Sell |
|
|||||
|
2023
Q2 | $10.3M | Sell |
|
|||||
|
2023
Q1 | $10.5M | Sell |
|
|||||
|
2022
Q4 | $12.3M | Sell |
|
|||||
|
2022
Q3 | $10.3M | Sell |
|
|||||
|
2022
Q2 | $12.5M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Buy |
|
|||||
|
2021
Q4 | $11.4M | Sell |
|
|||||
|
2021
Q3 | $11.9M | Sell |
|
|||||
|
2021
Q2 | $28.2M | Buy |
|
|||||
|
2021
Q1 | $23.2M | Buy |
|
|||||
|
2020
Q4 | $22.8M | Buy |
|
|||||
|
2020
Q3 | $24.6M | Sell |
|
|||||
|
2020
Q2 | $23.8M | Sell |
|
|||||
|
2020
Q1 | $20.7M | Sell |
|
|||||
|
2019
Q4 | $23.5M | Buy |
|
|||||
|
2019
Q3 | $20.8M | Buy |
|
|||||
|
2019
Q2 | $17.7M | Sell |
|
|||||
|
2019
Q1 | $19.3M | Sell |
|
|||||
|
2018
Q4 | $20.6M | Sell |
|
|||||
|
2018
Q3 | $21.8M | Buy |
|
|||||
|
2018
Q2 | $19.1M | Sell |
|
|||||
|
2018
Q1 | $19.1M | Buy |
|
|||||
|
2017
Q4 | $18.3M | Sell |
|
|||||
|
2017
Q3 | $17.7M | Sell |
|
|||||
|
2017
Q2 | $17.8M | Buy |
|
|||||
|
2017
Q1 | $16.4M | Sell |
|
|||||
|
2016
Q4 | $7.46M | Sell |
|
|||||
|
2016
Q3 | $9.45M | Buy |
|
|||||
|
2016
Q2 | $8.5M | Buy |
|